Growth Metrics

Zimmer Biomet Holdings (ZBH) Gains from Investment Securities (2016 - 2026)

Zimmer Biomet Holdings has reported Gains from Investment Securities over the past 18 years, most recently at $6.2 million for Q1 2026.

  • For Q1 2026, Gains from Investment Securities rose 1966.67% year-over-year to $6.2 million; the TTM value through Mar 2026 reached $6.9 million, down 44.35%, while the annual FY2024 figure was $5.4 million, 13.66% down from the prior year.
  • Gains from Investment Securities for Q1 2026 was $6.2 million at Zimmer Biomet Holdings, up from -$2.8 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $66.0 million in Q2 2023 and troughed at -$73.3 million in Q3 2023.
  • A 5-year average of $2.4 million and a median of $1.0 million in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 11800.0% in 2022 and later tumbled 2081.08% in 2023.
  • Year by year, Gains from Investment Securities stood at -$43.7 million in 2022, then soared by 50.11% to -$21.8 million in 2023, then soared by 87.16% to -$2.8 million in 2024, then changed by 0.0% to -$2.8 million in 2025, then skyrocketed by 321.43% to $6.2 million in 2026.
  • Business Quant data shows Gains from Investment Securities for ZBH at $6.2 million in Q1 2026, -$2.8 million in Q4 2025, and $3.5 million in Q3 2025.